AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Accelerated tocolysis lengthened triplet gestations. (Case-Control Study of 40 Women).

OB GYN News

| July 01, 2002 | Boschert, Sherry | COPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

LOS ANGELES -- Accelerated dosing of continuous subcutaneous terbutaline in women bearing triplets who were at risk of preterm delivery extended gestation by nearly 2 weeks and decreased admissions to the neonatal intensive care unit, Dr. Gary Stanziano.

In a retrospective matched case-control study of 40 women pregnant with triplets, mean gestational age at delivery was 33.3 weeks in those who received accelerated dosing and 31.5 weeks in those managed with customary dosing. The accelerated dosing group also had a greater percentage of deliveries that occurred at 35 weeks' gestation or later (83% vs. 25%), he said at the annual meeting of the American College of Obstetricians and Gynecologists.

Infants in the accelerated dosing group were less likely to be admitted to the neonatal intensive care unit (46% vs. 82%) and spent less time there (11 days vs. 20 days). Birth weights were significantly higher in the accelerated dosing group, he said Dr. Stanziano of Stamford, Conn.

The women were told to restrict physical activity and were managed with a transvaginal ultrasound of the cervix and corticosteroids. Home uterine activity ...

Related articles from newspapers, magazines, journals, and more
FDA Approves Accelerated Dosing Schedule for GlaxoSmithKline's Twinrix(R).
Press release article from: PR Newswire April 2, 2007 700+ words
...Recombinant) Vaccine], for an accelerated dosing schedule that consists of three doses...investigator. "Twinrix's new accelerated dosing schedule offers an option that could...completed the series of Twinrix on the accelerated dosing schedule had an immune response comparable...
CVBT Receives Permission to Proceed to the Final Dosing Group in Its U.S....
Press release article from: Business Wire October 4, 2005 700+ words
...Committee have reviewed safety data from the mid-dosing group of the ongoing Phase I clinical trial in no-option...patients and have given approval to proceed to the final dosing group. The current trial is a multi-center, dose escalation...
FDA approves accelerated dosing schedule for GSK's Twinrix.(Food and Drug...
Newspaper article from: Pharma Marketletter April 9, 2007 700+ words
...Administration has approved Twinrix (inactivated hepatitis A vaccine and hepatitis B recombinant vaccine) in an accelerated dosing schedule that consists of three doses given within three weeks, followed by a booster dose at 12 months. The...
Cardiome Announces Positive Phase 2b Results For Oral Vernakalant.
Press release article from: PR Newswire July 14, 2008 700+ words
...results demonstrated that the 500mg dosing group significantly reduced the rate of atrial...was greater than 90 days for the 500mg dosing group, compared to 27 days for the placebo...analysis. 51% of patients in the 500mg dosing group (n=150) completed the study in normal...
Cardiome Announces Positive Phase 2b Results for Oral Vernakalant.(Financial...
Newspaper article from: Clinical Trials Week July 28, 2008 700+ words
...results demonstrated that the 500mg dosing group significantly reduced the rate of atrial...was greater than 90 days for the 500mg dosing group, compared to 27 days for the placebo...analysis. 51% of patients in the 500mg dosing group (n=3D150) completed the study in...
Cardiome Announces Positive Phase 2a Results For Oral RSD1235.
Press release article from: PR Newswire September 13, 2006 700+ words
...and an interim analysis of the 300mg dosing group relative to the initial placebo group...announced on July 24, 2006. For the 300mg dosing group, 61% (33 of 54) of patients receiving...patients receiving placebo. For the 600mg dosing group, 61% (30 of 49) of patients receiving...
Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and...
Press release article from: PR Newswire March 17, 2008 700+ words
...efficacy benefit for the 500mg dosing group as compared to placebo (two...greater than 90 days for the 500mg dosing group, compared to 39 days for the...52% of patients in the 500mg dosing group (n=110) completed the study...
TEST - Jay 14 - Cardiome Announces Positive Interim Phase 2b Results for Oral...
Press release article from: PR Newswire May 28, 2008 700+ words
...efficacy benefit for the 500mg dosing group as compared to placebo (two...greater than 90 days for the 500mg dosing group, compared to 39 days for the...52% of patients in the 500mg dosing group (n=110) completed the study...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA